Search

everythinglearnresearchcommunity

for

Search:↓

Europe needs a clear system to watch over cosmetics for safety and to make sure product claims are true.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Cosmeceuticals may have potential but their effectiveness and market success are still uncertain.

More profitable TV stations have stricter ad approval rules, and bigger stations are generally stricter too.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The document warns against US clinics selling untested stem cell treatments without FDA approval.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Biofibre® hair implants are safe and effective for alopecia when proper procedures are followed, with high patient satisfaction.

The document suggests reevaluating the patent system to ensure public benefits from pharmaceutical privileges and to encourage more significant innovations.

The lecture concluded that drugs for human enhancement are here to stay and called for their responsible development and fair access.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

Some plant-based ingredients may help with hair growth and care, but more research is needed to confirm their effectiveness.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Synthetic hair fibers for hair restoration were controversial in 2009 due to health risks and lack of support from the International Society of Hair Restoration.

Pigmented concealing powders can improve the look of hair density for people with hair loss but need daily application and may not work well in wet conditions.

Men with hair loss feel it affects their emotions and life quality, and want more effective treatments.

Herbal depilatories are safer and cause fewer side effects than chemical ones for hair removal.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.